ARCH Venture Partners X, LLC

ARCH Venture Partners X, LLC is listed in filings as 10% Owner at Prime Medicine, Inc.. This profile follows SEC Form 4 activity through Oct 29, 2025, including purchase activity. Recent filings connect the profile to Prime Medicine, Inc. (PRME) and Neumora Therapeutics, Inc. Common Stock (NMRA). The current snapshot covers public activity from Aug 1, 2025 to Oct 29, 2025. Reported amounts are shown as $10.0M to $5.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.